Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative
|Autor||Navarro Garrido, Victoria
Sánchez Mejías, Elisabeth
Jiménez Muñoz, Sebastián
Muñoz Castro, Clara
Sánchez Varo, Raquel María
Dávila, José Carlos
Vizuete Chacón, María Luisa
Vitorica Ferrández, Francisco Javier
|Departamento||Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular|
|Publicado en||Frontiers in Aging Neuroscience, 10 (140), 1-8.|
|Tipo de documento||Artículo|
|Resumen||Microglial activation has been considered a crucial player in the pathological process of multiple human neurodegenerative diseases. In some of these pathologies, such as Amyotrophic Lateral Sclerosis or Multiple Sclerosis, ...
Microglial activation has been considered a crucial player in the pathological process of multiple human neurodegenerative diseases. In some of these pathologies, such as Amyotrophic Lateral Sclerosis or Multiple Sclerosis, the immune system and microglial cells (as part of the cerebral immunity) play a central role. In other degenerative processes, such as Alzheimer’s disease (AD), the role of microglia is far to be elucidated. In this “mini-review” article, we briefly highlight our recent data comparing the microglial response between amyloidogenic transgenic models, such as APP/PS1 and AD patients. Since the AD pathology could display regional heterogeneity, we focus our work at the hippocampal formation. In APP based models a prominent microglial response is triggered around amyloid-beta (Aβ) plaques. These strongly activated microglial cells could drive the AD pathology and, in consequence, could be implicated in the neurodegenerative process observed in models. On the contrary, the microglial response in human samples is, at least, partial or attenuated. This patent difference could simply reflect the lower and probably slower Aβ production observed in human hippocampal samples, in comparison with models, or could reflect the consequence of a chronic long-standing microglial activation. Beside this differential response, we also observed microglial degeneration in Braak V–VI individuals that, indeed, could compromise their normal role of surveying the brain environment and respond to the damage. This microglial degeneration, particularly relevant at the dentate gyrus, might be mediated by the accumulation of toxic soluble phospho-tau species. The consequences of this probably deficient immunological protection, observed in AD patients, are unknown.
|Cita||Navarro Garrido, V., Sánchez Mejías, ., Jiménez Muñoz, S., Muñoz Castro, ., Sánchez Varo, R.M., Dávila, J.C.,...,Vizuete Chacón, M.L. (2018). Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative. Frontiers in Aging Neuroscience, 10 (140), 1-8.|